Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Genet. mol. biol ; 34(2): 348-352, 2011. tab
Article Dans Anglais | LILACS | ID: lil-587761

Résumé

Cross-amplification was tested and variability in microsatellite primers (designed for Neotropical parrots) compared, in five macaw species, viz., three endangered blue macaws (Cyanopsitta spixii [extinct in the wild], Anodorhynchus leari [endangered] and Anodorhynchus hyacinthinus [vulnerable]), and two unthreatened red macaws (Ara chloropterus and Ara macao). Among the primers tested, 84.6 percent successfully amplified products in C. spixii, 83.3 percent in A. leari, 76.4 percent in A. hyacinthinus, 78.6 percent in A. chloropterus and 71.4 percent in A. macao. The mean expected heterozygosity estimated for each species, and based on loci analyzed in all the five, ranged from 0.33 (A. hyacinthinus) to 0.85 (A. macao). As expected, the results revealed lower levels of genetic variability in threatened macaw species than in unthreatened. The low combined probability of genetic identity and the moderate to high potential for paternity exclusion, indicate the utility of the microsatellite loci set selected for each macaw species in kinship and population studies, thus constituting an aid in planning in-situ and ex-situ conservation.

2.
Rev. AMRIGS ; 33(3): 202-4, jul.-set. 1989. tab
Article Dans Portugais | LILACS | ID: lil-87820

Résumé

A prevalência de S. aureus reistente a oxacilina foi obtida através da análise de 243 exames bacteriológicos em um hospital universitário no Brasil. A sensibilidade aos antibióticos foi determinada através do método de Kirby-Bauer. A resistenência a oxacilina foi de 57% Centro de Tratamento Intensivo (CTI), 36% na Cirurgia, 33% na Neonatologua, 29% na Pediatria, 24% na Medicina Interna e 12% na emergência. Com estes resultados, concluímos que o S. aureus resistente a oxacilina é um importante problema atual, principalmente na CTI


Sujets)
Humains , Mâle , Femelle , Infections à staphylocoques/traitement médicamenteux , Oxacilline/usage thérapeutique , Staphylococcus aureus/effets des médicaments et des substances chimiques , Brésil , Unités de soins intensifs , Oxacilline/effets indésirables , Résistance microbienne aux médicaments
SÉLECTION CITATIONS
Détails de la recherche